Villalpando, Juan Manuel
Leclerc, Bernard-Simon https://orcid.org/0009-0007-1386-7411
Le, Minh Tri
Hudon, Carol
Bolduc, Aline
Kergoat, Marie-Jeanne
,
Funding for this research was provided by:
Consortium for the Early Identification of Alzheimer's Disease-Quebec (Unknown)
Article History
Received: 25 April 2024
Accepted: 15 April 2025
First Online: 9 May 2025
Declarations
:
: Marie-Jeanne Kergoat, Juan Manuel Villalpando, and Carol Hudon are members of the Consortium for the Early Identification of Alzheimer’s Disease-Quebec (CIMA-Q) but did not receive any funding or influence for the submitted work. Minh Tri Le, a medical student, benefited from a summer scholarship from CIMA-Q. The other authors did not receive any funds, grants, or support from other organizations and have no competing, relevant financial or non-financial interests to disclose. No other potential conflicts of interest are reported by the authors. CIMA-Q, the Consortium pour l’Identification Précoce de la Maladie d’Alzheimer—Québec received funding from the Fonds d’Innovation Pfizer-FRQS for Alzheimer’s disease and related diseases, FRQS (Fonds de recherche du Québec-Santé), RQRV (Quebec Network for Research on Aging), Fondation Courtois (Neuromod project), and the Fondation Famille Lemaire.